Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Current Medicinal Chemistry|March 23, 2004
Serotonin(7) receptors (5-HT(7)Rs) and their ligandsM LeopoldoMedicina Oral, Patologia Oral Y Cirugia Bucal|August 16, 2017
Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?L Bagan, Y Jiménez, M Leopoldo, et al.Journal of Medicinal Chemistry|January 29, 2000
A structure-affinity relationship study on derivatives of N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a high-affinity and selective D(4) receptor ligandR Perrone, F Berardi, N A Colabufo, et al.Medicina Oral, Patologia Oral Y Cirugia Bucal|August 16, 2017
Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: Associated clinical characteristicsL Bagan, Y Jiménez, M Leopoldo, et al.Journal of Medicinal Chemistry|February 13, 1999
1-aryl-4-[(5-methoxy-1,2,3, 4-tetrahydronaphthalen-1-yl)alkyl]piperazines and their analogues: influence of the stereochemistry of the tetrahydronaphthalen-1-yl nucleus on 5-HT1A receptor affinity and selectivity versus alpha1 and D2 receptors. 5R Perrone, F Berardi, N A Colabufo, et al.Bioorganic & Medicinal Chemistry|July 6, 2000
1-Substituted-4-[3-(1,2,3,4-tetrahydro-5- or 7-methoxynaphthalen-1-yl)propyl]piperazines: influence of the N-1 piperazine substituent on 5-HT1A receptor affinity and selectivity versus D2 and alpha1 receptors. Part 6R Perrone, F Berardi, N A Colabufo, et al.Journal of Medicinal Chemistry|November 21, 1998
N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide: a potent and selective dopamine D4 ligandR Perrone, F Berardi, N A Colabufo, et al.Current Medicinal Chemistry|August 10, 2012
Activatable fluorescent probes: a new concept in optical molecular imagingE Lacivita, M Leopoldo, F Berardi, et al.Oral Diseases|January 29, 2016
Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosisJ Bagan, A Peydró, J Calvo, et al.Bioorganic & Medicinal Chemistry|May 30, 2001
A multireceptorial binding reinvestigation on an extended class of sigma ligands: N-[omega-(indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards sigma1 and EBP sitesF Berardi, S Ferorelli, N A Colabufo, et al.Pageof 3